These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16082156)

  • 1. High frequency of aspirin resistance in patients with acute coronary syndrome.
    Hobikoglu GF; Norgaz T; Aksu H; Ozer O; Erturk M; Nurkalem Z; Narin A
    Tohoku J Exp Med; 2005 Sep; 207(1):59-64. PubMed ID: 16082156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of acetylsalicylic acid resistance on prognosis of patients who have developed acute coronary syndrome during acetylsalicylic acid therapy.
    Hobikoglu GF; Norgaz T; Aksu H; Ozer O; Erturk M; Destegul E; Akyuz U; Unal Dai S; Narin A
    Can J Cardiol; 2007 Mar; 23(3):201-6. PubMed ID: 17347690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL
    Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of mean platelet volume on prognosis of patients with and without aspirin resistance in settings of non-ST-segment elevated acute coronary syndromes.
    Aksu H; Ozer O; Unal H; Hobikoglu G; Norgaz T; Buturak A; Soylu O; Narin A
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):686-93. PubMed ID: 19730245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major clinical vascular events and aspirin-resistance status as determined by the PFA-100 method among patients with stable coronary artery disease: a prospective study.
    Christiaens L; Ragot S; Mergy J; Allal J; Macchi L
    Blood Coagul Fibrinolysis; 2008 Apr; 19(3):235-9. PubMed ID: 18388505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms associated with in vitro aspirin resistance are not associated with clinical outcomes in patients with coronary artery disease who report regular aspirin use.
    Voora D; Horton J; Shah SH; Shaw LK; Newby LK
    Am Heart J; 2011 Jul; 162(1):166-72.e1. PubMed ID: 21742104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization.
    Frelinger AL; Li Y; Linden MD; Barnard MR; Fox ML; Christie DJ; Furman MI; Michelson AD
    Circulation; 2009 Dec; 120(25):2586-96. PubMed ID: 19996015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of exercise on platelet aggregation in patients with stable coronary artery disease: exercise induces aspirin resistant platelet activation.
    Pamukcu B; Oflaz H; Acar RD; Umman S; Koylan N; Umman B; Nisanci Y
    J Thromb Thrombolysis; 2005 Aug; 20(1):17-22. PubMed ID: 16133890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous MI After Non-ST-Segment Elevation Acute Coronary Syndrome Managed Without Revascularization: The TRILOGY ACS Trial.
    Lopes RD; Leonardi S; Neely B; Neely ML; Ohman EM; Ardissino D; Hamm CW; Goodman SG; Bhatt DL; White HD; Prabhakaran D; Martinez F; Nicolau JC; Winters KJ; Fox KA; Armstrong PW; Roe MT
    J Am Coll Cardiol; 2016 Mar; 67(11):1289-97. PubMed ID: 26988949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prior aspirin use and outcomes in acute coronary syndromes.
    Rich JD; Cannon CP; Murphy SA; Qin J; Giugliano RP; Braunwald E
    J Am Coll Cardiol; 2010 Oct; 56(17):1376-85. PubMed ID: 20946994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of aspirin resistance on outcome in patients with acute coronary syndrome and the effect of clopidogrel therapy in the prevention of major cardiovascular events.
    Pamukcu B; Oflaz H; Oncul A; Umman B; Mercanoglu F; Ozcan M; Meric M; Nisanci Y
    J Thromb Thrombolysis; 2006 Oct; 22(2):103-10. PubMed ID: 17008975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease.
    Lordkipanidzé M; Pharand C; Schampaert E; Turgeon J; Palisaitis DA; Diodati JG
    Eur Heart J; 2007 Jul; 28(14):1702-8. PubMed ID: 17569678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of aspirin resistance in patients with stable coronary artery disease: a prospective follow-up study (PROSPECTAR).
    Pamukcu B; Oflaz H; Onur I; Oncul A; Ozcan M; Umman B; Mercanoglu F; Meric M; Nisanci Y
    Blood Coagul Fibrinolysis; 2007 Mar; 18(2):187-92. PubMed ID: 17287637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for aspirin resistance in stable coronary artery patients by three different tests.
    Chakroun T; Addad F; Abderazek F; Ben-Farhat M; Hamdi S; Gamra H; Hassine M; Ben-Hamda K; Samama MM; Elalamy I
    Thromb Res; 2007; 121(3):413-8. PubMed ID: 17553552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and angiographic characteristics of coronary artery disease in young adults: a single centre study.
    Maroszyńska-Dmoch EM; Wożakowska-Kapłon B
    Kardiol Pol; 2016; 74(4):314-21. PubMed ID: 26365941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease.
    Larsen SB; Grove EL; Neergaard-Petersen S; Würtz M; Hvas AM; Kristensen SD
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28780510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin resistance in Indian patients with coronary artery disease and cardiovascular events.
    Thomson VS; John B; George P; Joseph G; Jose J
    J Postgrad Med; 2009; 55(4):252-6. PubMed ID: 20083870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
    Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
    Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Harrington RA; Becker RC; Ezekowitz M; Meade TW; O'Connor CM; Vorchheimer DA; Guyatt GH
    Chest; 2004 Sep; 126(3 Suppl):513S-548S. PubMed ID: 15383483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-related effect of aspirin on laboratory-defined platelet aggregation and clinical outcome after coronary stenting.
    Kojuri J; Mahmoody Y; Zangbar Sabegh B; Jannati M; Mahboodi A; Khalili A
    Cardiovasc Ther; 2010 Jun; 28(3):147-52. PubMed ID: 20557313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.